CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease

Abstract

Alzheimer's disease (AD) is the most common cause of dementia worldwide. Although, many putative biomarkers are reported for AD, only a few have been validated in the clinical setting. Ubiquitin levels increase in cerebrospinal fluid (CSF) of patients with AD, but its diagnostic value is not clear. In this present study we evaluate the performance of ubiquitin as a diagnostic marker and deduce a statistical association with disease pathology in AD. Ubiquitin levels were estimated in subjects with AD, other forms of dementias, neurological disorders and healthy age matched population. The levels of ubiquitin were significantly higher in subjects with AD when compared with other groups (p<0.0001). A significant positive correlation was observed between ubiquitin, tau and apolipoprotein Eε4 genotype; with Aβ42 the correlation was negative. By comparing the effect size of the association between ubiquitin and a diagnosis of AD, we find that high ubiquitin levels are specific for AD. We obtained an odds ratio of 5.6 (95% CI 5.0-7.7) for ubiquitin, towards a diagnosis of AD based on clinical criteria, CSF biomarker signature (Aβ42+tau) and apolipoprotein Eε4 genotype. Hence, all our findings taken together provide a strong statistical association linking ubiquitin to the pathology in AD. We also find that, the performance of ubiquitin as a diagnostic marker is comparable to that of CSF Aβ42 or tau or apolipoprotein Eε4 genotype considered individually.

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

“…AD is also associated with the loss of synapses, oxidative stress & mitochondrial structural and functional abnormalities, inflammatory responses, changes in cholinergic neurotransmission, hormonal changes and cell cycle abnormalities [3, 4, 5, 6, 7]. …”

Altered Functional Connectivity of Cognitive-Related Cerebellar Subregions in Alzheimer’s Disease

“…Alzheimer’s disease (AD) is the most common cause of dementia manifested as progressive memory deficits and cognitive impairment (Seeley et al, 2009; Pievani et al, 2011a), which may be caused by the deposition of amyloid-β plaques, neurofibrillary tangles and neuronal loss (Braak and Braak, 1991; Kandimalla et al, 2011, 2014). These AD pathological changes attack the cognitive related specific regions and disrupt the connectivity among these regions, which leads to the cognitive decline.…”

Regularized Linear Discriminant Analysis of EEG Features in Dementia Patients

“…Alzheimer’s disease is the most common form of dementia among the elderly population (Jeong, 2004; Kandimalla et al, 2011, 2013, 2014). The second most common form of dementia is VaD (Roman, 2002), affecting approximately 20% of all dementia cases worldwide (Dubois and Hebert, 2001).…”